Characterization of a novel <scp>OTX</scp>2‐driven stem cell program in Group 3 and Group 4 medulloblastoma

Margaret Stromecki(University of Manitoba), Tamra E. Werbowetski‐Ogilvie(Baylor College of Medicine)
Molecular Oncology
January 29, 2018
Cited by 25


Related Papers